FdaApplication
ANDA 214017
Identifiers
- fda_app_no: ANDA214017
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2021-02-18 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DROXIDOPA | DROXIDOPA | 200MG | CAPSULE;ORAL |
| DROXIDOPA | DROXIDOPA | 300MG | CAPSULE;ORAL |
| DROXIDOPA | DROXIDOPA | 100MG | CAPSULE;ORAL |
3 products